SNGXSOLIGENIX, INC.

Nasdaq www.soligenix.com


$ 0.42 $ -0.01 (-2.81 %)    

Friday, 26-Apr-2024 15:39:51 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.415
$ 0.42
$ 0.00 x 0
$ 0.00 x 0
$ 0.42 - $ 0.43
$ 0.37 - $ 4.20
269,354
na
3.22M
$ 0.70
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-21-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-29-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-18-2021 03-31-2021 10-Q
13 03-30-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-30-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-13-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-26-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-11-2018 03-31-2018 10-Q
25 03-15-2018 12-31-2017 10-K
26 11-06-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 05-11-2017 03-31-2017 10-Q
29 03-27-2017 12-31-2016 10-K
30 11-10-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-24-2016 12-31-2015 10-K
34 11-12-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-25-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 08-11-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 soligenix-extends-patent-protection-for-its-filovirus-vaccine-platform-to-uk-and-south-africa

Includes thermostabilized Ebola vaccines MarVax and SuVax Includes nanoemulsion adjuvant compatible with lyophilization

 why-alcoa-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...

 sp-500-down-over-1-us-retail-sales-increase-07-in-march

U.S. stocks turned lower toward the end of trading, with the S&P 500 falling more than 1% on Monday. The Dow traded down 0...

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 why-is-penny-stock-soligenix-trading-higher-on-monday

Soligenix secures FDA orphan drug designation for MarVax, a vaccine against Marburg marburgvirus (MARV). Benefits include marke...

 crude-oil-down-1-charles-schwab-sales-top-estimates

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow tra...

 dow-jumps-over-300-points-goldman-sachs-posts-upbeat-earnings

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.8...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 recap-soligenix-q4-earnings
Recap: Soligenix Q4 Earnings
03/15/2024 13:35:05

 soligenix-fy-gaap-eps-079-beats-082-estimate-sales-80000k-beat-79750k-estimate

Soligenix (NASDAQ:SNGX) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.82) by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION